Corcept TherapeuticsCORT
那斯達克 · USD
115.70
+1.72
(+1.51%)
收盤 09/10 03:59 (UTC+8)
盤後
117.96
+2.26
(+1.95%)
09/10 03:59 (UTC+8)
Corcept TherapeuticsCORT
115.70
+1.72
(+1.51%)
財務數據
損益表
- 1.47
- 1.64
- 1.83
- 1.82
- 1.57
- 1.94
- 2.08
- 2.02
- 1.65
- 2.56
- 8.42
- 11.57
- 11.45
- -0.36
- -13.57
- 23.67
- 6.79
- -2.66
- -18.42
- 55.33
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 256,147 | 164,903 | 202,125 | 207,638 | 194,430 | 157,214 | 181,890 | 182,546 | 163,796 | 146,808 |
營業成本 | 4,061 | 2,883 | 2,545 | 4,596 | 3,433 | 2,403 | 2,956 | 2,867 | 2,524 | 2,535 |
營業毛利 | 252,086 | 162,020 | 199,580 | 203,042 | 190,997 | 154,811 | 178,934 | 179,679 | 161,272 | 144,273 |
營業費用 | 210,786 | 211,621 | 195,093 | 192,823 | 164,322 | - | 153,672 | 133,081 | 125,681 | - |
研發費用 | 53,890 | 66,265 | 64,856 | 68,846 | 60,471 | 60,735 | 70,300 | 59,336 | 58,746 | 58,505 |
推銷及管理費用 | 156,896 | 145,356 | 130,237 | 123,977 | 103,851 | 90,660 | 83,372 | 73,745 | 66,935 | 56,268 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 41,300 | -49,601 | 4,487 | 10,219 | 26,675 | 3,416 | 25,262 | 46,598 | 35,591 | 29,500 |
其他收入及費用 | 4,631 | 4,886 | 5,423 | 5,024 | 5,017 | 6,202 | 6,698 | 6,346 | 6,005 | 5,493 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 45,931 | -44,715 | 9,910 | 15,243 | 31,692 | 9,618 | 31,960 | 52,944 | 41,596 | 34,993 |
所得稅 | 2,944 | -12,954 | -14,378 | -4,425 | -3,457 | -10,929 | 1,214 | 5,731 | 6,108 | 7,231 |
稅後純益 | 42,987 | -31,761 | 24,288 | 19,668 | 35,149 | 20,547 | 30,746 | 47,213 | 35,488 | 27,762 |
基本每股稅後盈餘(元) | 0.40 | -0.30 | 0.23 | 0.19 | 0.33 | 0.19 | 0.29 | 0.45 | 0.34 | 0.27 |
稀釋每股稅後盈餘(元) | 0.39 | -0.30 | 0.20 | 0.16 | 0.29 | 0.17 | 0.25 | 0.41 | 0.32 | 0.25 |
基本平均股數(千股) | 105377.00 | 104435.00 | 103695.00 | 103545.00 | 104111.00 | 104106.00 | 103643.00 | 103371.00 | 103118.00 | 102791.00 |
稀釋平均股數(千股) | 118385.00 | 104435.00 | 119855.00 | 119439.00 | 120485.00 | 119819.00 | 118459.00 | 113723.00 | 111244.00 | 109915.00 |
還原基本每股稅後盈餘(元) | 0.40 | -0.30 | 0.23 | 0.19 | 0.33 | 0.19 | 0.29 | 0.45 | 0.34 | 0.27 |
還原稀釋每股稅後盈餘(元) | 0.39 | -0.30 | 0.20 | 0.16 | 0.29 | 0.17 | 0.25 | 0.41 | 0.32 | 0.25 |
還原基本平均股數(千股) | 105,377 | 104,435 | 103,695 | 103,545 | 104,111 | 104,106 | 103,643 | 103,371 | 103,118 | 102,791 |
還原稀釋平均股數(千股) | 118,385 | 104,435 | 119,855 | 119,439 | 120,485 | 119,819 | 118,459 | 113,723 | 111,244 | 109,915 |
EBITDA(千元) | 46,087 | -44,953 | 9,299 | 14,715 | 30,849 | 8,387 | 30,229 | 50,577 | 38,772 | 32,313 |